| 查看: 783 | 回复: 8 | |||
| 【奖励】 本帖被评价7次，作者wangye增加金币 5.25 个 | |||
| 当前主题已经存档。 | |||
[资源]
Bioequivalence Studies in Drug Development
|
|||
|
希望得到你的支持！ By Dieter Hauschke, Volker Steinijans, Iris Pigeot, Publisher: Wiley Number Of Pages: 328 Publication Date: 2007-03-16 Sales Rank: 695834 ISBN / ASIN: 0470094753 EAN: 9780470094754 Binding: Hardcover Manufacturer: Wiley Studio: Wiley Studies in bioequivalence are the commonly accepted method to demonstrate therapeutic equivalence between two medicinal products. Savings in time and cost are substantial when using bioequivalence as an established surrogate marker of therapeutic equivalence. For this reason the design, performance and evaluation of bioequivalence studies have received major attention from academia, the pharmaceutical industry and health authorities. Bioequivalence Studies in Drug Development focuses on the planning, conducting, analysing and reporting of bioequivalence studies, covering all aspects required by regulatory authorities. This text presents the required statistical methods, and with an outstanding practical emphasis, demonstrates their applications through numerous examples using real data from drug development. Includes all the necessary pharmacokinetic background information. Presents parametric and nonparametric statistical techniques. Describes adequate methods for power and sample size determination. Includes appropriate presentation of results from bioequivalence studies. Provides a practical overview of the design and analysis of bioequivalence studies. Presents the recent developments in methodology, including population and individual bioequivalence. Reviews the regulatory guidelines for such studies, and the existing global discrepancies. Discusses the designs and analyses of drug-drug and food-drug interaction studies. Bioequivalence Studies in Drug Development is written in an accessible style that makes it ideal for pharmaceutical scientists, clinical pharmacologists, and medical practitioners, as well as biometricians working in the pharmaceutical industry. It will also be of great value for professionals from regulatory bodies assessing bioequivalence studies. http://rapidshare.com/files/37201570/Haus_BeSiDDMaA.rar [ Last edited by wangye on 2007-10-17 at 19:25 ] |
回复此楼» 猜你喜欢
关于代码变化问题，想知道的进来
已经有20人回复
-
应该是93bebmhtak前后十一个字符比较关键
已经有11人回复
-
这样的filecode谁见过
已经有21人回复
-
filecode与中标关系的预测
已经有5人回复
-
fileCode有新解读？
已经有18人回复
-
关于filecode，很负责任的告诉大家
已经有7人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
关于豆爷回答的JTJC与%2F数量
已经有7人回复
-
2026国自然放榜时间
已经有3人回复
-
国基金的申报应该改成非等额制，评价高的钱多评价低的钱少，但是增加资助率
已经有7人回复
2楼2007-10-17 20:44:55
4楼2007-10-20 08:12:51
5楼2008-02-29 16:55:59
7楼2008-03-04 02:12:05
简单回复
2007-10-18 15:01
回复
2008-03-03 00:00
回复
